Law No. 20 of 2021 Only Grants Resident Doctors a Food Allowance

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Public Health Law No. 89 of 1981 was indeed amended once in 2021, by Law No. 20 of 2021 to amend the Public Health Law No. 89 of 1981. But that law contains only 2 articles, and its content is to authorise the Ministry of Health, together with the Ministry of Finance, to determine the amount of a cash food allowance and grant it to senior resident doctors. It has nothing to do with medical devices, drug registration, vigilance, recalls, or labelling. GRZAN devotes a separate article to it because the claim that the 2021 amendment of the public health law equals device regulatory reform still circulates in Chinese-language content and is regularly used as evidence that Iraq has recently tightened device regulation.

  • Law No. 20 of 2021 amends the Public Health Law and contains exactly 2 articles.
  • Its sole subject is a cash food allowance for senior resident doctors, set with the Ministry of Finance.
  • Unlike the phantom-law finding in Article 07, this law’s text was obtained, so this finding is stated firmly.
  • No device, vigilance, recall, or labelling content appears anywhere in the amendment.

2. Legal basis

The amendment law, the amended statute, and the index records relied on are tabulated below.

InstrumentNumberPublication dateProvisions
Amendment Law: Law No. 20 of 2021 to amend the Public Health Law No. 89 of 1981No. 20 (2021)2021; effective from its publication in the Official Gazette2 articles in total (no sub-article numbering)
Amended parent statute: Public Health Law No. 89 of 1981, as amendedNo. 89 (1981)Published in the gazette 1981-08-17106 articles in total; this amendment touches no device-related provisions
ECOLEX index recordLEX-FAOC2049822021Abstract page (not the text)
FAOLEX full-text PDFirq204982.pdf2021Full text of 2 articles

Source grade. The existence of Law No. 20 of 2021, its article count (2), and its content (cash food allowance) are primary, verified (ECOLEX index record and FAOLEX full text). The associated claim that the 2021 amendment brought device regulatory reform has no official provision supporting it: the full text of Law No. 20 of 2021 has been obtained and its 2 articles contain no device, vigilance, recall, or labelling content. Because the source site was reachable, this point can be stated definitively; it is a different evidentiary situation from the not found, no definitive assertion wording used in Article 07, and the two wordings must not be mixed.

Excerpts:

  • ECOLEX abstract: this law consisting of 2 articles aims at granting the Ministry of Health and Environment, in coordination with the Ministry of Finance, the power to determine the amount of the cash allowance and to grant senior resident doctors the cash allowance for food.
  • Entry into force: from publication in the Official Gazette (no separate transitional period is stated).
  • Warning: the abstract uses the old ministry name, Ministry of Health and Environment. The current Iraqi ministry name is the Ministry of Health. The discrepancy itself shows that secondary abstracts are not updated when bodies are renamed; relying on abstracts instead of texts imports wrong body names along the way.

3. Expert insights

Insight 1: a 2-article law cannot carry any regulatory reform. The most reliable indicator of what an amendment changed is the article count and the subject of the text. Law No. 20 of 2021 has 2 articles on a personnel and finance matter, granting a cash allowance to a named group. Genuine regulatory reform legislation typically carries definition clauses, procedure clauses, and penalty clauses, running to dozens of articles; the EU MDR body has 123 articles, and China’s 2021 medical device regulation has 107. Using the article count as the first sieve eliminates most mis-transmissions within minutes.

Insight 2: the error mechanism is headline plus truncation. The standard secondary phrasing is that in 2021 Iraq amended the Public Health Law, a sentence that is literally correct while omitting the amendment’s content. Readers and later republicers naturally associate amending the parent law with industry regulatory change, and out of that association the 2021 Iraqi device regulation reform is invented. The only countermeasure: whenever a source says a country amended a law in a given year, read down to the provision level before citing.

Insight 3: why this particular mis-transmission is so stubborn. It forms a false mutual corroboration with the phantom law of Article 07: one source says a 2010 device law exists, another says the public health law was amended in 2021, and both point toward Iraq having a device regulatory system that is tightening. GRZAN refutes each claim on its own, never by asking whether sources support one another; two mutually supporting sources that both descend from secondary publications remain one and the same error.

Insight 4: how the correct statement should read. The accurate account of Iraqi legislative change in 2021 is: the Public Health Law received one amendment, on resident doctors’ food allowance; as of the verification date, no new statutory provision on device definition, classification, registration, or vigilance has been found in Iraq. Device rule changes facing companies occur at the level of ministerial instructions and notices, not at the level of statute.

4. Practical recommendations

  • Wherever client material contains the phrase 2021 Iraqi device regulatory reform, GRZAN replaces it with the accurate statement above and attaches the article count (2) and subject of Law No. 20 of 2021.
  • When citing any foreign amendment law, record three fields together: number and year, article count, and a summary of the provisions’ subject. Without all three, the citation does not enter external documents.
  • For body names, follow the current official ministry name. The Ministry of Health and Environment in secondary abstracts is the old name and must not be copied into tender documents.
  • Build a year, amendment, subject table listing all four amendments, No. 53 (1986), No. 71 (1988), No. 54 (2001), No. 20 (2021), so that a client’s question whether anything changed in a given year starts from the table.
  • In client briefings, state one judgment plainly: Iraqi device compliance does not change in the law. Tracking effort belongs on MOH and KIMADIA ministerial documents, using the ledger method given in Article 05.

5. Verification checklist

  • □ In ECOLEX retrieve LEX-FAOC204982 and verify the abstract wording and the 2 articles phrasing.
  • □ Download irq204982.pdf from FAOLEX and confirm the article count is 2 and that no device, drug, vigilance, recall, or labelling wording appears.
  • □ Verify the entry-into-force clause (from publication in the Official Gazette) and complete the gazette issue number.
  • □ Verify the current ministry name and confirm external documents use the Ministry of Health rather than the old name in the abstract.
  • □ Recheck the Public Health Law amendment list and confirm no new amendment law after 2021 up to the verification date.
  • □ Search the client’s existing material for 2021 device reform wording and correct each occurrence.
  • □ Recheck whether the official documents cited here have been superseded by later instructions or decisions (verification date for this article: 29 October 2026).

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iraqi market. Our team manages KMOC (Kurdistan) and federal MOH registration procedures, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail